Pharmaceuticals, Volume 17, Issue 1
2024 January - 143 articles
Cover Story: The advent of CRISPR/Cas technologies has enabled us to manipulate the genetic code with various possibilities. However, controlling the dose, time, and location of action remains a significant challenge in the application of said technologies. Small molecules offer a simple and cost-effective way to regulate biological processes. This review explores the various mechanisms by which the CRISPR/Cas9 machinery can be influenced with the help of small molecules. While the indirect influence on the machinery by small molecules is discussed, the primary focus is on direct interactions between small molecules and (engineered) Cas9 or sgRNA. These findings highlight the promise of small-molecule-mediated control of CRISPR/Cas9 activity for developing more precise, efficient, and controllable genome-editing strategies. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.